# Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma Patients

> **NCT02053298** · PHASE4 · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 30 (actual)

## Conditions studied

- Open Angle Glaucoma

## Interventions

- **DRUG:** Timolol & Dorzolamide

## Key facts

- **NCT ID:** NCT02053298
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02053298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02053298, "Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02053298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*